TWO SIGMA INVESTMENTS, LP - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$20,674,195
-53.3%
816,839
-40.6%
0.05%
-59.1%
Q1 2023$44,267,427
+77.5%
1,374,338
+1.7%
0.13%
+62.8%
Q4 2022$24,942,303
-17.7%
1,351,154
+20.4%
0.08%
-24.3%
Q3 2022$30,289,000
+535.8%
1,121,823
+225.5%
0.10%
+543.8%
Q2 2022$4,764,000
+123.3%
344,688
+215.1%
0.02%
+166.7%
Q1 2022$2,133,000
+47.2%
109,396
+23.2%
0.01%
+100.0%
Q4 2021$1,449,000
+76.1%
88,806
+171.4%
0.00%0.0%
Q3 2020$823,000
+157.2%
32,722
+149.6%
0.00%
+50.0%
Q2 2020$320,000
-83.1%
13,109
-89.8%
0.00%
-86.7%
Q1 2020$1,894,000
+124.9%
127,967
+146.6%
0.02%
+400.0%
Q4 2019$842,000
+79.1%
51,902
+43.2%
0.00%
+50.0%
Q2 2019$470,000
-74.5%
36,242
-69.0%
0.00%
-66.7%
Q1 2019$1,844,000
+90.1%
117,012
+199.7%
0.01%
+100.0%
Q3 2018$970,000
-75.7%
39,039
-73.2%
0.00%
-75.0%
Q2 2018$3,999,000
+171.3%
145,677
+204.4%
0.01%
+140.0%
Q1 2018$1,474,000
-51.0%
47,855
-43.1%
0.01%
-50.0%
Q4 2017$3,008,000
+82.9%
84,142
+74.8%
0.01%
+25.0%
Q4 2015$1,645,000
+53.6%
48,146
-6.8%
0.01%
+60.0%
Q1 2015$1,071,00051,6730.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders